Lipopolysaccharide (LPS)-Induced Tumor Necrosis Factor-Alpha (TNF-ɑ) Levels and Health Care Associated Infection

Shiva Manwatkar1, Anil Kumar Saroj1, Sandip Kumar2

  • 1Division of Pediatric Intensive Care & Pulmonology, Department of Pediatrics, IMS BHU, Varanasi, UP, India.

PubMed

Insights

This study found that lower levels of tumor necrosis factor-alpha (TNF-α) in children with multi-organ dysfunction syndrome (MODS) were associated with health care associated infections (HAI) and poorer outcomes, including mortality.

Area of Science:

  • Pediatric Critical Care Medicine
  • Immunology
  • Infectious Diseases

Background:

  • Multi-organ dysfunction syndrome (MODS) is a critical condition in children.
  • Tumor necrosis factor-alpha (TNF-α) plays a role in inflammation and infection.
  • Health care associated infections (HAI) are common complications in critically ill children.

Purpose of the Study:

  • To investigate the relationship between lipopolysaccharide (LPS)-induced TNF-α levels and HAI in children with MODS.
  • To determine the association of TNF-α levels with the duration of MODS and patient survival.

Main Methods:

  • LPS-induced TNF-α levels were measured in 67 children with MODS on day 3.
  • Data collected included Pediatric Index of Mortality (PIM-3), cultures, diagnosis, HAI status, MODS duration, and survival outcomes.
  • Statistical analysis compared TNF-α levels between different patient groups.

Main Results:

  • 94% of children with MODS exhibited reduced TNF-α levels (<200 pg/ml).
  • Lower TNF-α levels were significantly associated with prolonged MODS (≥7 days), development of HAI (especially ventilator-associated pneumonia), and non-survival.
  • Health care associated infection (HAI) was independently linked to reduced TNF-α levels (p=0.01).

Conclusions:

  • Reduced TNF-α levels are a potential biomarker for increased risk of HAI and adverse outcomes in pediatric MODS.
  • The findings suggest an important role for TNF-α in the pathogenesis of MODS and its complications.
  • Further research could explore therapeutic strategies targeting TNF-α to improve outcomes in these critically ill children.